Publications
Primary tabs
, “(Plenary speaker) Bex, flies and audiotapes – Jacquot Award Presentation”, in 47th Annual Scientific Meeting of the Australia and New Zealand Society of Nephrology, Adelaide, Australia, September, 2011.
, “(Plenary speaker) Closing the Gap for Indigenous Australians with chronic kidney disease: Research, policy and practice”, in Australian Association for Clinical Biochemistry Indigenous Health Symposium, Brisbane, Australia, November, 2011.
, “(Plenary speaker) Facilitating Indigenous Australians’ access to medicines and necessary care”, in 3rd Joint Medicines Policy Conference, Canberra, Australia, August, 2011.
, “(Plenary Speaker) Kidney disease in 2020: a dialysis unit in every GP super clinic? ”, in Australasian Dialysis Nephrology Transplant Workshop, Pokolbin, Australia, March, 2011.
, “(Plenary speaker) “The door is locked. They sit behind closed doors”: Qualitative research to understand and address barriers to better kidney health ”, in 8th International Workshop on Kidney Disease in Indigenous, Minority, and Disadvantaged Populations, Victoria B.C., Canada, April, 2011.
, “Rationale for the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events (CONCORDANCE)”, CSANZ, vol. 20. Heart, Lung & Circulation 2011;20:S40, Perth, Australia, August, p. S40, 2011.
, “Simpler solutions to prevent chronic disease: A polypill-based strategy to prevent major cardiovascular events. ”, in ASEANZ Cardiovascular and Lipid Forum, Melbourne, Australia, 2011.
, “Socioeconomic disparities in stroke rates and outcome: pooled analysis of stroke incidence studies in Australia and New Zealand”, Medical Journal of AustraliaMedical Journal of Australia, vol. 195, pp. 10-4, 2011.
, “The Central Australia Renal Study – Can we provide Sustainable and appropriate renal services to Aboriginal people from remote communities across the region? ”, in South Australia Renal Group, Adelaide, Australia , 2011.
, “The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality”, Intensive Care Medicine, vol. 37, pp. 816-23, 2011.
, “The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial”, Lancet, vol. 377, pp. 2181-92, 2011.
, “What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study”, BMJ OpenBMJ Open, vol. 1, p. e000372, 2011.
, “Applying evidence into routine clinical care at a unit level: the exemplar of renal anaemia management”, Nephrology (Carlton)Nephrology (Carlton), vol. 15, pp. 429-33, 2010.
, “Aspirin benefit increases as eGFR declines: Results from a randomised controlled trial in a hypertensive population”, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 49., Perth, Australia, September, 2010.
, “Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial”, Journal of the American College of CardiologyJournal of the American College of Cardiology, vol. 56, pp. 956-65, 2010.
, “Assessment of kidney function in type 2 diabetes”, NephrologyNephrology, vol. 15, pp. S146-S161, 2010.
, “Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study)”, Med J AustMedical Journal of Australia, vol. 192, pp. 254-9, 2010.
, “Community preferences for the allocation of solid organs for transplantation: a systematic review”, Transplantation, vol. 89, pp. 796-805, 2010.
, “Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes”, NephrologyNephrology, vol. 15, pp. S195-S203, 2010.
, “Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis”, Value HealthValue in Health, vol. 13, pp. 196-208, 2010.
, “Diabetes, heart and kidney disease: The health reform challenge we must address. Australian Diabetes Educator Association ACT Branch Conference, Canberra, February 2010.”, in Australian Diabetes Educator Association ACT Branch Conference, Canberra, Australia, February, 2010.
, “Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease”, European Heart JournalEuropean Heart Journal, vol. 31, pp. 2888-96, 2010.
, “Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis”, Lancet, vol. 375, pp. 1875-84, 2010.
, “Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial”, J HypertensJournal of Hypertension, vol. 28, pp. 1141-9, 2010.
, “Factors associated with survival in elderly dialysis patients”, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 27., Perth, Australia, September, 2010.